Clarify Medical yesterday filed an SEC Form D disclosing the sale of nearly $16 million in equity, according to an SEC filing.
In its equity funding round, the San Diego-based company raised approximately $15.8 million from 19 investors, with the first sale noted on Oct. 22, 2019.
Clarify Medical is still looking for $6 million in the round, which would bring the equity funding round to $21.8 million. The company did not disclose how it plans to use the proceeds.
The equity sale comes after the company announced last month that it raised $18 million in a Series A funding round in which proceeds would go toward commercializing and developing its Clarify home light therapy system for patients with dermatologic conditions.
The Clarify system is a connected phototherapy system that is designed to be used through an app on a smartphone to manage dose, frequency and duration of targeted narrowband light therapy. Physicians can prescribe a treatment regimen that can be controlled by the Clarify system.
